Ting-Lin, M., Liu, Y., Campbell, M. E., Erbe, R., Zander, A., Jin, A., Zheng, X., Stein, M. M., Beauchamp, K. A., Terdich, B., Sherry, C., Grayhack, E., Omstead, A. N., Wagner, P., Chiou, V. L., Hyun, S. W., Sangli, C., Nimeiri, H., Bartlett, D. L., Zaidi, A. H. (2026). Multimodal immune profile score (IPS) signature as a predictive response biomarker to immune checkpoint inhibitors in tumor mutational burden-high (TMB-H) advanced pancancer cohorts.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e14590